{"hands_on_practices": [{"introduction": "The fundamental distinction between small-molecule and neuropeptide transmitters begins with their unique storage mechanisms. Small synaptic vesicles (SSVs) and large dense-core vesicles (LDCVs) differ dramatically in size, which has profound implications for their signaling roles. This first practice provides a quantitative foundation for this concept, starting from first principles of chemistry and geometry. By calculating and comparing the number of transmitter molecules in each type of vesicle, you will develop a concrete understanding of how vesicle volume and molecular concentration interact to define the quantal content of a synapse [@problem_id:2705899].", "problem": "In cellular and molecular neuroscience, small-molecule neurotransmitters such as glutamate are packaged in small clear synaptic vesicles (SSVs), whereas neuropeptides are packaged in large dense-core vesicles (LDCVs). Consider an SSV containing glutamate with diameter $40\\,\\mathrm{nm}$ and an LDCV containing a neuropeptide with diameter $120\\,\\mathrm{nm}$. Assume both vesicle types are spherical, their lumens are fully aqueous, solutes are uniformly distributed, and volume excluded by dense-core matrix and macromolecular crowding can be neglected. The intravesicular glutamate concentration is $100\\,\\mathrm{mM}$ and the intravesicular peptide concentration is $10\\,\\mathrm{mM}$. Use the definition of concentration, the definition of Avogadro’s constant, and the geometric volume of a sphere as your starting points. Take Avogadro’s constant as $N_{A}=6.022\\times 10^{23}\\,\\mathrm{mol}^{-1}$.\n\nStarting from these bases, derive the expression for the number of molecules per vesicle and compute:\n- the number of glutamate molecules per SSV,\n- the number of peptide molecules per LDCV,\n- and the fold difference given by the ratio $N_{\\text{peptide}}/N_{\\text{glutamate}}$.\n\nRound each reported quantity to $3$ significant figures. Report your final answer as a row matrix $\\big[ N_{\\text{glutamate}},\\, N_{\\text{peptide}},\\, N_{\\text{peptide}}/N_{\\text{glutamate}} \\big]$ with no units.", "solution": "The goal is to compute the number of molecules packaged per vesicle in two cases and then form their ratio. We begin from fundamental definitions.\n\nBy definition, the chemical amount $n$ in moles is related to concentration $C$ and volume $V$ by $n = C V$. The number of molecules $N$ is related to the chemical amount by $N = n N_{A}$, where $N_{A}$ is Avogadro’s constant. Combining these gives\n$$\nN = C\\,V\\,N_{A}.\n$$\n\nThe vesicles are assumed spherical. For a sphere of diameter $d$, the volume is\n$$\nV = \\frac{\\pi}{6} d^{3}.\n$$\nTo apply this to vesicles, we must convert diameters in nanometers to meters for $V$ in $\\mathrm{m}^{3}$, and then convert to liters because concentrations are given in $\\mathrm{mol/L}$. The conversion is $1\\,\\mathrm{m}^{3} = 10^{3}\\,\\mathrm{L}$ and $1\\,\\mathrm{nm} = 10^{-9}\\,\\mathrm{m}$.\n\nSmall clear synaptic vesicle (glutamate):\n- Diameter $d_{\\mathrm{SSV}} = 40\\,\\mathrm{nm} = 40\\times 10^{-9}\\,\\mathrm{m}$.\n- Volume in $\\mathrm{m}^{3}$:\n$$\nV_{\\mathrm{SSV}} = \\frac{\\pi}{6} d_{\\mathrm{SSV}}^{3}\n= \\frac{\\pi}{6} \\left(40\\times 10^{-9}\\right)^{3}\\,\\mathrm{m}^{3}.\n$$\nCompute $d_{\\mathrm{SSV}}^{3}$:\n$$\n\\left(40\\times 10^{-9}\\right)^{3} = 64000 \\times 10^{-27} = 6.4\\times 10^{-23}\\,\\mathrm{m}^{3}.\n$$\nThus\n$$\nV_{\\mathrm{SSV}} = \\frac{\\pi}{6} \\left(6.4\\times 10^{-23}\\right)\n= \\left(\\frac{\\pi}{6}\\right) 6.4\\times 10^{-23}\\,\\mathrm{m}^{3}.\n$$\nConvert to liters:\n$$\nV_{\\mathrm{SSV,L}} = \\left(\\frac{\\pi}{6}\\right) 6.4\\times 10^{-23}\\times 10^{3}\n= \\left(\\frac{\\pi}{6}\\right) 6.4\\times 10^{-20}\\,\\mathrm{L}.\n$$\nNumerically, $\\frac{\\pi}{6}\\approx 0.5236$, so\n$$\nV_{\\mathrm{SSV,L}} \\approx 0.5236 \\times 6.4\\times 10^{-20}\n= 3.351\\,\\times 10^{-20}\\,\\mathrm{L}.\n$$\nThe glutamate concentration is $C_{\\mathrm{glu}} = 100\\,\\mathrm{mM} = 0.100\\,\\mathrm{mol/L}$. Therefore, the number of glutamate molecules is\n$$\nN_{\\mathrm{glu}} = C_{\\mathrm{glu}}\\,V_{\\mathrm{SSV,L}}\\,N_{A}\n= 0.100 \\times \\left(3.351\\times 10^{-20}\\right) \\times \\left(6.022\\times 10^{23}\\right).\n$$\nGroup powers of ten and multiply mantissas:\n$$\nN_{\\mathrm{glu}} = \\left(0.100 \\times 3.351 \\times 6.022\\right) \\times 10^{(-20+23)}\n= \\left(0.100 \\times 20.179\\right) \\times 10^{3}\n= 2.0179\\times 10^{3}.\n$$\nThus, to $3$ significant figures,\n$$\nN_{\\mathrm{glu}} \\approx 2.02\\times 10^{3}.\n$$\n\nLarge dense-core vesicle (peptide):\n- Diameter $d_{\\mathrm{LDCV}} = 120\\,\\mathrm{nm} = 120\\times 10^{-9}\\,\\mathrm{m}$.\n- Note that volume scales as $d^{3}$. Since $120/40 = 3$, the LDCV volume is $3^{3} = 27$ times the SSV volume. We can use this scaling to avoid recomputation:\n$$\nV_{\\mathrm{LDCV,L}} = 27 \\times V_{\\mathrm{SSV,L}} = 27 \\times 3.351\\times 10^{-20} = 9.0477\\times 10^{-19}\\,\\mathrm{L}.\n$$\nAlternatively, a direct computation using $V = \\frac{\\pi}{6} d^{3}$ yields the same value.\nThe peptide concentration is $C_{\\mathrm{pep}} = 10\\,\\mathrm{mM} = 0.010\\,\\mathrm{mol/L}$. Therefore,\n$$\nN_{\\mathrm{pep}} = C_{\\mathrm{pep}}\\,V_{\\mathrm{LDCV,L}}\\,N_{A}\n= 0.010 \\times \\left(9.0477\\times 10^{-19}\\right) \\times \\left(6.022\\times 10^{23}\\right).\n$$\nCompute:\n$$\nN_{\\mathrm{pep}} = \\left(0.010 \\times 9.0477 \\times 6.022\\right) \\times 10^{(-19+23)}\n= \\left(0.010 \\times 54.484\\right) \\times 10^{4}\n= 5.4484\\times 10^{3}.\n$$\nThus, to $3$ significant figures,\n$$\nN_{\\mathrm{pep}} \\approx 5.45\\times 10^{3}.\n$$\n\nFold difference:\nThe ratio simplifies cleanly using scaling arguments:\n$$\n\\frac{N_{\\mathrm{pep}}}{N_{\\mathrm{glu}}}\n= \\frac{C_{\\mathrm{pep}}}{C_{\\mathrm{glu}}}\\,\\frac{V_{\\mathrm{LDCV,L}}}{V_{\\mathrm{SSV,L}}}\n= \\frac{0.010}{0.100}\\times 27 = 2.7.\n$$\nNumerically using the computed molecule counts,\n$$\n\\frac{N_{\\mathrm{pep}}}{N_{\\mathrm{glu}}} \\approx \\frac{5.4484\\times 10^{3}}{2.0179\\times 10^{3}} \\approx 2.700,\n$$\nwhich is consistent with the analytical scaling. To $3$ significant figures,\n$$\n\\frac{N_{\\text{peptide}}}{N_{\\text{glutamate}}} \\approx 2.70.\n$$\n\nInterpretation in the context of classification: Although neuropeptides are macromolecules and typically present at lower concentrations than small-molecule transmitters, the substantially larger volume of large dense-core vesicles can yield comparable or even greater numbers of molecules per vesicle under the given conditions. Here, the LDCV contains approximately $2.70$ times as many peptide molecules as the SSV contains glutamate molecules.\n\nRounded to $3$ significant figures, the requested row matrix is $\\big[ 2.02\\times 10^{3},\\; 5.45\\times 10^{3},\\; 2.70 \\big]$.", "answer": "$$\\boxed{\\begin{pmatrix}2.02\\times 10^{3}  5.45\\times 10^{3}  2.70\\end{pmatrix}}$$", "id": "2705899"}, {"introduction": "Beyond static storage capacity, the two neurotransmitter classes are distinguished by the dynamics of their supply chains. The rapid, local recycling pathway for SSVs contrasts sharply with the slower, soma-dependent biogenesis and transport required for LDCVs. This exercise models the functional consequences of these distinct logistical constraints on synaptic function. By calculating the time required to replenish vesicle pools after intense activity, you will explore how these kinetic differences determine a neuron's ability to sustain different forms of signaling over time [@problem_id:2705885].", "problem": "In a single presynaptic bouton, two physically and biogenetically distinct vesicle classes mediate transmitter release: small synaptic vesicles (SSVs), which package classical small-molecule neurotransmitters, and large dense-core vesicles (LDCVs), which package neuropeptides. Under basal conditions, each bouton maintains a finite, steady-state pool of each vesicle class through ongoing biosynthesis, transport, and endocytic recycling. Assume that, immediately following a high-frequency depletion protocol, exocytosis empties a subset of these vesicles and the bouton is then silenced so that no further release occurs during recovery.\n\nTake the following scientifically plausible parameters per bouton:\n- Baseline pool sizes before depletion: $N_{0,\\mathrm{SSV}} = 400$ vesicles and $N_{0,\\mathrm{LDCV}} = 20$ vesicles.\n- The depletion protocol triggers fusion of $100$ SSVs and $5$ LDCVs.\n- During recovery, refilling proceeds at a constant, rate-limited capacity for each class that does not depend on current pool size until the baseline is reattained, with rates $r_{\\mathrm{SSV}} = 2$ SSV/s and $r_{\\mathrm{LDCV}} = 0.02$ LDCV/s.\n- Neglect any additional losses or releases during recovery, and assume no upper bound before the baseline is reached other than the baseline pool itself.\n\nStarting from the definitions of vesicle conservation and a constant refilling rate, derive and compute the time required for each vesicle class to recover to $80\\%$ of its baseline pool size. Express both times in seconds and round your answers to three significant figures. Provide your final pair of times as a row vector in the order SSV then LDCV.", "solution": "The classification into small synaptic vesicles (SSVs) and large dense-core vesicles (LDCVs) reflects distinct cargo classes (small-molecule neurotransmitters versus neuropeptides) and distinct trafficking and refilling constraints. Here, we use the conservation of vesicle number under recovery and the definition of a constant refilling rate to determine the time to reattain a specified fraction of the baseline pool.\n\nLet $N_{\\mathrm{SSV}}(t)$ and $N_{\\mathrm{LDCV}}(t)$ denote the sizes of the SSV and LDCV pools at time $t$ after the depletion protocol, respectively. Let the baseline pool sizes be $N_{0,\\mathrm{SSV}}$ and $N_{0,\\mathrm{LDCV}}$. Immediately after depletion, the remaining pools are\n$$\nN_{\\mathrm{SSV}}(0) = N_{0,\\mathrm{SSV}} - 100, \\quad N_{\\mathrm{LDCV}}(0) = N_{0,\\mathrm{LDCV}} - 5.\n$$\nGiven $N_{0,\\mathrm{SSV}} = 400$ and $N_{0,\\mathrm{LDCV}} = 20$, we have\n$$\nN_{\\mathrm{SSV}}(0) = 400 - 100 = 300, \\quad N_{\\mathrm{LDCV}}(0) = 20 - 5 = 15.\n$$\n\nAssuming a constant refilling rate, the time evolution up to the baseline is linear:\n$$\n\\frac{dN_{\\mathrm{SSV}}}{dt} = r_{\\mathrm{SSV}}, \\quad \\frac{dN_{\\mathrm{LDCV}}}{dt} = r_{\\mathrm{LDCV}},\n$$\nwith $r_{\\mathrm{SSV}} = 2$ SSV/s and $r_{\\mathrm{LDCV}} = 0.02$ LDCV/s. Integrating with respect to time gives\n$$\nN_{\\mathrm{SSV}}(t) = N_{\\mathrm{SSV}}(0) + r_{\\mathrm{SSV}}\\, t, \\quad N_{\\mathrm{LDCV}}(t) = N_{\\mathrm{LDCV}}(0) + r_{\\mathrm{LDCV}}\\, t,\n$$\nfor $t$ until the respective baselines are reached.\n\nWe seek the time $t_{\\mathrm{SSV}}$ and $t_{\\mathrm{LDCV}}$ such that each pool reaches $80\\%$ of its baseline:\n$$\nN_{\\mathrm{SSV}}(t_{\\mathrm{SSV}}) = 0.8\\, N_{0,\\mathrm{SSV}}, \\quad N_{\\mathrm{LDCV}}(t_{\\mathrm{LDCV}}) = 0.8\\, N_{0,\\mathrm{LDCV}}.\n$$\nSubstituting the integrated forms yields\n$$\nN_{\\mathrm{SSV}}(0) + r_{\\mathrm{SSV}}\\, t_{\\mathrm{SSV}} = 0.8\\, N_{0,\\mathrm{SSV}}, \\quad N_{\\mathrm{LDCV}}(0) + r_{\\mathrm{LDCV}}\\, t_{\\mathrm{LDCV}} = 0.8\\, N_{0,\\mathrm{LDCV}}.\n$$\nSolving for the times gives\n$$\nt_{\\mathrm{SSV}} = \\frac{0.8\\, N_{0,\\mathrm{SSV}} - N_{\\mathrm{SSV}}(0)}{r_{\\mathrm{SSV}}}, \\quad t_{\\mathrm{LDCV}} = \\frac{0.8\\, N_{0,\\mathrm{LDCV}} - N_{\\mathrm{LDCV}}(0)}{r_{\\mathrm{LDCV}}}.\n$$\n\nInsert the values:\n- For SSVs,\n$$\n0.8\\, N_{0,\\mathrm{SSV}} = 0.8 \\times 400 = 320, \\quad N_{\\mathrm{SSV}}(0) = 300, \\quad r_{\\mathrm{SSV}} = 2,\n$$\nso\n$$\nt_{\\mathrm{SSV}} = \\frac{320 - 300}{2} = \\frac{20}{2} = 10.\n$$\n\n- For LDCVs,\n$$\n0.8\\, N_{0,\\mathrm{LDCV}} = 0.8 \\times 20 = 16, \\quad N_{\\mathrm{LDCV}}(0) = 15, \\quad r_{\\mathrm{LDCV}} = 0.02,\n$$\nso\n$$\nt_{\\mathrm{LDCV}} = \\frac{16 - 15}{0.02} = \\frac{1}{0.02} = 50.\n$$\n\nTherefore, the recovery times to $80\\%$ of baseline are $t_{\\mathrm{SSV}} = 10$ s and $t_{\\mathrm{LDCV}} = 50$ s. Rounding each to three significant figures yields $10.0$ and $50.0$.", "answer": "$$\\boxed{\\begin{pmatrix}10.0  50.0\\end{pmatrix}}$$", "id": "2705885"}, {"introduction": "While the classification of signaling molecules into small-molecule transmitters and neuropeptides provides a powerful organizing framework, neuroscience is filled with important exceptions. Understanding why certain molecules defy this neat categorization is crucial for a sophisticated view of neuronal communication. This final practice challenges you to think like an experimental neurophysiologist by interpreting a set of pharmacological results to classify a signaling pathway that violates the core rules of vesicular release, helping you master the criteria that define conventional neurotransmission [@problem_id:2705929].", "problem": "A neuron-to-neuron signaling system is being evaluated to determine whether its mediator fits within the conventional classification of small-molecule neurotransmitters versus neuropeptides. As a foundational base, assume the following widely accepted definitions and facts in cellular and molecular neuroscience:\n\n- Both small-molecule transmitters and neuropeptides are stored in membrane-bound vesicles acidified by vacuolar-type adenosine triphosphatase (V-ATPase) and are released by calcium ion ($Ca^{2+}$)-triggered fusion that requires the Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor (SNARE) machinery. Vesicle loading of small molecules depends on specific vesicular transporters (for example, the vesicular monoamine transporter, VMAT, or the vesicular glutamate transporter, VGLUT). Neuropeptides require biosynthesis as prepropeptides in the soma with endoplasmic reticulum and Golgi processing, and are packaged into dense-core vesicles.\n- Exocytotic release is inhibited when vesicles are de-acidified (for example, V-ATPase blockade), when SNAREs are proteolyzed (for example, by clostridial toxins), or when extracellular $Ca^{2+}$ influx that triggers fusion is prevented. By contrast, non-vesicular signaling will be insensitive to these manipulations, but will depend on the mediator’s synthesis and downstream target engagement.\n- Diffusive signaling of small, membrane-permeant molecules follows Fick’s law, with flux $J = -D \\nabla C$, and does not require vesicular encapsulation or SNARE-mediated fusion to cross membranes.\n\nYou perform a set of experiments in acute brain slices in which a postsynaptic neuron is depolarized to activate a putative retrograde signal that transiently suppresses a presynaptic terminal’s release probability. Across different conditions, you measure both the presynaptic suppression and a pH-sensitive vesicle reporter in the presynaptic terminal. Pharmacological and molecular tools used include: a V-ATPase inhibitor (to collapse synaptic vesicle proton gradients), a SNARE protease (to cleave synaptobrevin and block fusion), the nitric oxide synthase (NOS) inhibitor $N^{\\omega}$-nitro-L-arginine methyl ester, a nitric oxide scavenger (cell-impermeant hemoglobin), and a soluble guanylyl cyclase (sGC) inhibitor. Appropriate controls for health of the slice and postsynaptic depolarization are in place.\n\nWhich pattern of results most rigorously supports the conclusion that the mediator violates the vesicular storage and $Ca^{2+}$-triggered exocytotic release criteria central to both small-molecule and neuropeptide classifications?\n\nA. Presynaptic suppression persists despite V-ATPase inhibition and SNARE proteolysis, with no change in the presynaptic vesicle pH reporter, but the suppression is abolished by extracellular hemoglobin and by the sGC inhibitor; it is also prevented by NOS inhibition in the postsynaptic neuron.\n\nB. Presynaptic suppression is abolished by VMAT blockade and by VGLUT blockade, is enhanced by monoamine oxidase inhibition, and is eliminated by SNARE proteolysis; extracellular hemoglobin has no effect and the sGC inhibitor is without effect.\n\nC. Presynaptic suppression is abolished by disrupting Golgi trafficking and microtubules, requires high-frequency stimulation, is eliminated by chelation of extracellular $Ca^{2+}$ with ethylene glycol-bis($\\beta$-aminoethyl ether)-$N,N,N^{\\prime},N^{\\prime}$-tetraacetic acid (EGTA), and is unaffected by NOS inhibition or the sGC inhibitor.\n\nD. Presynaptic suppression is insensitive to V-ATPase inhibition but is abolished by SNARE proteolysis; it is unaffected by NOS inhibition, partially reduced by extracellular hemoglobin, and unaffected by the sGC inhibitor; the presynaptic vesicle pH reporter shows sustained alkalinization during the suppression.", "solution": "The question asks to identify a pattern of experimental results that proves a signaling mediator operates outside the conventional framework for both small-molecule and neuropeptide transmitters. The core criteria for conventional neurotransmitters, as defined in the problem, are vesicular storage and SNARE-dependent, $Ca^{2+}$-triggered exocytotic release. Therefore, a mediator that violates this framework must show signaling that is independent of these mechanisms.\n\nLet's analyze the canonical non-vesicular retrograde messenger, nitric oxide (NO), as a reference:\n1.  **Synthesis**: Produced on demand by nitric oxide synthase (NOS).\n2.  **Release**: Diffuses across membranes; it is not stored in or released from vesicles.\n3.  **Action**: Activates soluble guanylyl cyclase (sGC) in the target cell.\n4.  **Pharmacology**: Its pathway is blocked by NOS inhibitors, extracellular NO scavengers (like hemoglobin), and sGC inhibitors. Critically, it is unaffected by drugs that target vesicular release, such as V-ATPase inhibitors or SNARE proteases.\n\nNow, let's evaluate each option based on this understanding:\n\n**A. Presynaptic suppression persists despite V-ATPase inhibition and SNARE proteolysis, with no change in the presynaptic vesicle pH reporter, but the suppression is abolished by extracellular hemoglobin and by the sGC inhibitor; it is also prevented by NOS inhibition in the postsynaptic neuron.**\n- *Vesicular Release Violation*: The signal persists despite blocking vesicle acidification (V-ATPase inhibitor) and vesicle fusion (SNARE proteolysis). This is the key negative evidence that decisively rules out conventional vesicular release.\n- *Positive Identification*: The signal is blocked by a NOS inhibitor, an NO scavenger (hemoglobin), and an sGC inhibitor. This is the textbook pharmacological profile for NO signaling.\n- *Conclusion*: This option provides a complete and rigorous case, both invalidating the conventional mechanism and identifying a known non-conventional one. This is the correct answer.\n\n**B. Presynaptic suppression is abolished by VMAT blockade and by VGLUT blockade... and is eliminated by SNARE proteolysis...**\n- This describes a classic small-molecule transmitter that requires vesicular transporters (VMAT, VGLUT) and SNARE-dependent release. This *confirms* a conventional mechanism, rather than violating it.\n\n**C. Presynaptic suppression is abolished by disrupting Golgi trafficking and microtubules... requires high-frequency stimulation, is eliminated by chelation of extracellular $Ca^{2+}$...**\n- This describes a classic neuropeptide that requires the secretory pathway for synthesis/transport and Ca$^{2+}$-dependent exocytosis for release. This also *confirms* a conventional mechanism.\n\n**D. Presynaptic suppression is insensitive to V-ATPase inhibition but is abolished by SNARE proteolysis...**\n- This result is contradictory and confusing. SNARE-dependent release implies exocytosis, which typically requires vesicular loading that is sensitive to V-ATPase inhibitors (at least for small molecules). This option does not provide a clear, rigorous refutation of the vesicular model.\n\nTherefore, option A provides the most rigorous evidence that the mediator violates the established criteria for neurotransmitter classification.", "answer": "$$\\boxed{A}$$", "id": "2705929"}]}